TrimRx's Blog

Wegovy is not physically addictive, but psychological dependence on weight management medication differs from substance addiction. Here’s what recovery

Research shows GLP-1 agonists like Wegovy may reduce Alzheimer’s risk by up to 54% through anti-inflammatory pathways—here’s what the clinical evidence

Wegovy doesn’t cause gambling addiction through direct neurochemical action, but GLP-1 receptor changes can unmask compulsive behaviors in predisposed

Wegovy doesn’t treat nicotine dependence — it targets GLP-1 receptors for weight loss, not addiction pathways. Here’s what the research shows.

Wegovy may trigger compulsive shopping in some patients through dopamine pathway changes. We explain the mechanism, warning signs, and what to do if it

Wegovy doesn’t directly treat social anxiety, but weight loss can improve confidence. Here’s what clinical evidence shows about GLP-1 medications and

Mounjaro hair loss affects 5–8% of patients during rapid weight reduction. Here’s the biological mechanism, timeline, and prevention strategies.

Hit a plateau on Mounjaro? Weight loss stalls are common after 3–4 months due to metabolic adaptation. We explain why it happens and what works to restart

Building muscle on Mounjaro requires higher protein intake, strategic resistance training, and overcoming GLP-1’s appetite suppression. Here’s how to do